history of hypertension, history of diabetes, pre-EVAR hypogastric intervention, side of wound, incision type (vertical or horizontal), operative times, history of smoking, and death rates were not statistically different between the two groups.
Objectives: Clostridium difficile infection (C.Diff inf) is considered a national health problem. In 2017, the Centers for Medicare and Medicaid Services (CMS) and the Centers for Disease Control and Prevention -National Health Safety Network (CDC-NHSN) includes C.Diff inf as a measure for in-hospital-acquired condition (HAC) reduction program. Implications of C.Diff inf in health care setting will include loss of revenue for health systems as well as poor outcomes for affected patients. We sought to examine its impact on patients undergoing vascular surgery procedures.
Methods: A cohort of patients undergoing vascular procedures (between January 2014 and January 2016) as well as those with C.Diff inf was identified from the hospital billing and CDC-NHSN database, respectively. Statistical analysis were performed comparing patients with and without C.Diff inf after a vascular procedure as well as those admitted for vascular or nonvascular indication and having C.Diff inf. Two-sample t-test was used to compare the continuous variables of age, body mass index, length of stay (LOS), and total hospital cost. Patient comorbidities including binary variables of death, readmission, insurance status were compared using two proportion test using the CDC statistical calculator (P < .05 was determined significant).
Results: We identified 1656 patients undergoing vascular procedures. C.Diff inf was identified in 2.23% (n ¼ 37) after vascular procedures. During the same period, there were 971 other C.Diff inf patients admitted for nonvascular indications. As shown in the Fig, patients with C.Diff inf after vascular surgery have significantly higher total hospital cost (P ¼ .015), LOS (P ¼ .029), need for dialysis (P ¼ .037), and death (P ¼ .045), while the readmission (P ¼ .191) and insurance status (P ¼ .585) were not significant. The Table results show higher total cost (P ¼ .031), LOS (P ¼ .090), and need for dialysis (P ¼ .017) for patients with C.Diff inf admitted for vascular indication compared to nonvascular indications. Expected loss of revenue is w$65,976 per patient. 
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Complications of Percutaneous Endovascular Repair for Ruptured Aortic Abdominal Aneurysms Are Uncommon
Elina Quiroga, Sherene Shalhub, Nam Tran, Benjamin W. Starnes, Niten Singh. University of Washington, Seattle, Wash Objectives: Percutaneous access and repair of femoral arteries (Perclose technique) for endovascular aneurysm repair (EVAR) has been described; however, its role in the management of ruptured aortic abdominal aneurysm (rAAA) is yet to be defined. The aim of this study was to evaluate whether percutaneous access and repair of femoral arteries for ruptured EVAR (rEVAR) can be safely performed.
Methods: This was a single-center, prospective study of rAAA repair between 2005 and 2013. Patients who underwent percutaneous access were reviewed. Those who underwent open repair, aortouniiliac repair, or died during the index procedure were excluded. Demographics, operative time, and type of procedures performed were analyzed. Outcome measures included percutaneous closure device success rate, access site complications, and need for reintervention.
Results: A total of 226 rAAA presented to our institution during this time period, and 76 patients underwent successful rEVAR, for a total of 152 common femoral arteries analyzed. There were no differences in the baseline characteristics of those who had an attempted percutaneous access vs those who did not (Table) . Perclose technique was attempted in 74% of patients and was successful in 87.5% of patients. A total of 67% of the Perclose failures were treated with a primary repair, and 33% required a patch angioplasty. Complications after percutaneous repair were rare (6%) and included the following: one patient required a thrombectomy and fasciotomy on postoperative day 1, two patients developed femoral arteries pseudoaneurysms, one resolved without intervention and one was repaired 3 months after rAAA. None of the percutaneous access or repair patients developed wound infections. Operating time was significantly shorter in patients that had percutaneous repair (136 minutes vs 221 minutes; P ¼ .04). Hospital length of stay was not different between successful Perclose, failed Perclose, or no attempted Perclose (9 vs 16.9 vs 15.8 days, respectively; P ¼ .071). Mortality was not different as well (18.4% vs 25% vs 23.8%. respectively; P ¼ .885).
Conclusions: The Perclose technique of common femoral artery for rEVAR is feasible and can be performed with excellent results. Furthermore, the Perclose technique leads to shorter operative times, which can be crucial in these acutely ill patients. Complications are few and did not impact length of stay. We recommend an aggressive percutaneous first approach for the management of these patients. 
